FI934106A - Foereningar mot cancer - Google Patents

Foereningar mot cancer Download PDF

Info

Publication number: FI934106A
Authority: FI; Finland
Prior art keywords: foereningar; mot; cancer; mot cancer; foereningar mot
Prior art date: 1991-03-19

Application number

FI934106A

Other languages

English (en)

Other versions

FI934106A0 (fi

Inventor

Graham Michael Fraser Bisset

Ann Lesley Jackman

Duncan Ian Jodrell

Original Assignee

British Tech Group

Ici Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-19

Filing date

1993-09-20

Publication date

1993-11-18

1993-09-20 Application filed by British Tech Group, Ici Plc filed Critical British Tech Group

1993-09-20 Publication of FI934106A0 publication Critical patent/FI934106A0/fi

1993-11-18 Publication of FI934106A publication Critical patent/FI934106A/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FI934106A 1991-03-19 1993-09-20 Foereningar mot cancer FI934106A (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB919105771A GB9105771D0 (en)	1991-03-19	1991-03-19	Anti-cancer compounds
PCT/GB1992/000476 WO1992016512A1 (en)	1991-03-19	1992-03-18	Anti-cancer compounds

Publications (2)

Publication Number	Publication Date
FI934106A0 FI934106A0 (fi)	1993-09-20
FI934106A true FI934106A (fi)	1993-11-18

Family

ID=10691801

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI934106A FI934106A (fi)	1991-03-19	1993-09-20	Foereningar mot cancer

Country Status (18)

Country	Link
US (1)	US5444061A (fi)
EP (1)	EP0509643A1 (fi)
JP (1)	JPH06505974A (fi)
AU (1)	AU655970B2 (fi)
CA (1)	CA2106583A1 (fi)
CZ (1)	CZ195393A3 (fi)
FI (1)	FI934106A (fi)
GB (2)	GB9105771D0 (fi)
HU (1)	HUT67177A (fi)
IE (1)	IE920853A1 (fi)
IL (1)	IL101281A0 (fi)
MX (1)	MX9201183A (fi)
NO (1)	NO933341L (fi)
NZ (1)	NZ242023A (fi)
SK (1)	SK100993A3 (fi)
TW (1)	TW203608B (fi)
WO (1)	WO1992016512A1 (fi)
ZA (1)	ZA921985B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9205907D0 (en) *	1992-03-18	1992-04-29	Cancer Res Inst Royal	Anti-cancer compounds
GB9223352D0 (en) *	1992-11-06	1992-12-23	Ici Plc	Tricyclic compounds
GB9408936D0 (en) *	1994-05-05	1994-06-22	Cancer Res Inst	Anti-cancer compounds
IL123164A (en) *	1995-08-30	2001-03-19	Searle & Co	Meta-guanidine urea thiourea or azacyclic amino benzoic acid derivatives and pharmaceutical compositions containing them
GB9904275D0 (en)	1999-02-24	1999-04-21	Cancer Res Campaign Tech	Anti-cancer compounds
US7230000B1 (en) *	1999-10-27	2007-06-12	Cytokinetics, Incorporated	Methods and compositions utilizing quinazolinones
US6545004B1 (en) *	1999-10-27	2003-04-08	Cytokinetics, Inc.	Methods and compositions utilizing quinazolinones
US7671200B2 (en) *	1999-10-27	2010-03-02	Cytokinetics, Inc.	Quinazolinone KSP inhibitors
JP2005529076A (ja) *	2002-02-15	2005-09-29	サイトキネティクス・インコーポレーテッド	キナゾリノンの合成
US7214800B2 (en)	2002-05-09	2007-05-08	Cytokinetics, Inc.	Compounds, compositions, and methods
MXPA04011074A (es) *	2002-05-09	2005-06-08	Cytokinetics Inc	Compuestos de pirimidinona, composiciones y metodos.
US7038048B2 (en) *	2002-05-23	2006-05-02	Cytokinetics, Inc.	3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use
CA2489367A1 (en) *	2002-06-14	2003-12-24	Cytokinetics, Inc.	Compounds, compositions, and methods
US20030236430A1 (en) *	2002-06-21	2003-12-25	Allen David Robert	Preparation of protected amino acids
AU2003256805A1 (en) *	2002-07-23	2004-02-09	Cytokinetics, Inc.	Compounds compositions and methods
WO2004018058A2 (en) *	2002-08-21	2004-03-04	Cytokinetics, Inc.	Compounds, compositions, and methods
AU2003277079A1 (en) *	2002-09-30	2004-05-04	Cytokinetics, Inc.	Compounds, compositions, and methods
US20050197327A1 (en) *	2003-11-03	2005-09-08	Gustave Bergnes	Compounds, compositions, and methods
JP2007510660A (ja) *	2003-11-07	2007-04-26	サイトキネティクス・インコーポレーテッド	化合物、組成物及び方法
JP2007513154A (ja) *	2003-12-08	2007-05-24	サイトキネティクス・インコーポレーテッド	化合物、組成物及び方法
CN101646670A (zh)	2007-04-11	2010-02-10	默克阿泼洛发股份公司	18f-标记的叶酸酯
AU2015308350B2 (en)	2014-08-29	2020-03-05	Tes Pharma S.R.L.	Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
JP2022500499A (ja)	2018-09-07	2022-01-04	ピクセラピューティクス，インコーポレイテッド	Ｅｉｆ４ｅ阻害剤およびその使用
MX2022010944A (es)	2020-03-03	2022-11-09	Pic Therapeutics Inc	Inhibidores del factor de iniciacion de traduccion eucariotica 4e (eif4e) y sus usos.
CN118019739A (zh)	2021-08-25	2024-05-10	皮克医疗公司	Eif4e抑制剂及其用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0031237B1 (en) *	1979-12-19	1984-10-17	National Research Development Corporation	Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
GB8513754D0 (en) *	1985-05-31	1985-07-03	Jones T R	Anti-cancer quinazoline derivatives
US4746659A (en) *	1985-12-30	1988-05-24	Sri International	Diastereomers of 10-alkyl-10-deazaminopterins and process for preparing the same
GB8607683D0 (en) *	1986-03-27	1986-04-30	Ici Plc	Anti-tumor agents
US5187167A (en) *	1986-03-27	1993-02-16	Imperial Chemical Industries Plc	Pharmaceutical compositions comprising quinazolin-4-one derivatives
GB8625019D0 (en) *	1986-10-18	1986-11-19	Wellcome Found	Compounds
GB8707053D0 (en) *	1987-03-25	1987-04-29	Ici Plc	Anti-tumour agents
US4767761A (en) *	1987-11-04	1988-08-30	Dana-Farber Cancer Institute, Inc.	Ornithine derivatives and their use as methotrexate-resistant cell inhibitors
GB8727737D0 (en) *	1987-11-26	1987-12-31	Ici Plc	Antitumour agents
GB8809978D0 (en) *	1988-04-27	1988-06-02	Ici Plc	Anti-tumour agents
US5252573A (en) *	1988-12-15	1993-10-12	Imperial Chemical Industries Plc	Anti-tumor agents
GB8829296D0 (en) *	1988-12-15	1989-01-25	Ici Plc	Anti-tumour compounds
US4996207A (en) *	1990-01-18	1991-02-26	Nair Madhavan G	Three new non-polyglutamatable deazaaminopterins
ATE126033T1 (de) *	1990-05-17	1995-08-15	Smith & Nephew United Inc	Elektrisch leitender und adstringierender film sowie filmbildende zusammensetzung zur verwendung auf der haut.
ZA913730B (en) *	1990-05-30	1992-02-26	Ici Plc	Anti-tumor compounds

1991
- 1991-03-19 GB GB919105771A patent/GB9105771D0/en active Pending
1992
- 1992-03-18 US US08/122,473 patent/US5444061A/en not_active Expired - Fee Related
- 1992-03-18 IE IE085392A patent/IE920853A1/en unknown
- 1992-03-18 WO PCT/GB1992/000476 patent/WO1992016512A1/en not_active Application Discontinuation
- 1992-03-18 ZA ZA921985A patent/ZA921985B/xx unknown
- 1992-03-18 HU HU9302636A patent/HUT67177A/hu unknown
- 1992-03-18 EP EP92302304A patent/EP0509643A1/en not_active Withdrawn
- 1992-03-18 GB GB9205906A patent/GB2253849B/en not_active Expired - Fee Related
- 1992-03-18 IL IL101281A patent/IL101281A0/xx unknown
- 1992-03-18 MX MX9201183A patent/MX9201183A/es unknown
- 1992-03-18 SK SK1009-93A patent/SK100993A3/sk unknown
- 1992-03-18 AU AU13716/92A patent/AU655970B2/en not_active Expired - Fee Related
- 1992-03-18 CA CA002106583A patent/CA2106583A1/en not_active Abandoned
- 1992-03-18 JP JP4506050A patent/JPH06505974A/ja active Pending
- 1992-03-19 CZ CS931953A patent/CZ195393A3/cs unknown
- 1992-04-27 TW TW081103276A patent/TW203608B/zh active
- 1992-05-18 NZ NZ242023A patent/NZ242023A/en unknown
1993
- 1993-09-20 FI FI934106A patent/FI934106A/fi not_active Application Discontinuation
- 1993-09-20 NO NO933341A patent/NO933341L/no unknown

Also Published As

Publication number	Publication date
ZA921985B (en)	1993-09-20
EP0509643A1 (en)	1992-10-21
NO933341L (no)	1993-11-18
HUT67177A (en)	1995-02-28
GB9105771D0 (en)	1991-05-01
CZ195393A3 (en)	1994-07-13
SK100993A3 (en)	1994-08-10
NO933341D0 (no)	1993-09-20
GB2253849A (en)	1992-09-23
IL101281A0 (en)	1992-11-15
JPH06505974A (ja)	1994-07-07
AU1371692A (en)	1992-10-21
AU655970B2 (en)	1995-01-19
NZ242023A (en)	1993-12-23
HU9302636D0 (en)	1993-12-28
US5444061A (en)	1995-08-22
MX9201183A (es)	1994-06-30
IE920853A1 (en)	1992-09-23
GB2253849B (en)	1995-01-18
TW203608B (fi)	1993-04-11
FI934106A0 (fi)	1993-09-20
WO1992016512A1 (en)	1992-10-01
GB9205906D0 (en)	1992-04-29
CA2106583A1 (en)	1992-09-20

Publication	Publication Date	Title
FI934106A (fi)	1993-11-18	Foereningar mot cancer
ATE137279T1 (de)	1996-05-15	Stoffauflauf
ATA131391A (de)	1992-09-15	Reibring
FI930976A (fi)	1993-09-06	Mot tumoer riktande foerfarande och aemne
FI934447A (fi)	1993-10-08	Nytt immunhaemmande aemne fraon strptomyces braegensis
ATA39792A (de)	1994-11-15	Maehwerk
ATE163916T1 (de)	1998-03-15	Ethyl-6-formyloxy-4-hexenoat
ATA9892A (de)	1994-04-15	Formstein
ATA67791A (de)	1992-05-15	Rollski
BR9100599A (pt)	1992-09-29	Engrenagem autocompensadora
FI910133A0 (fi)	1991-01-10	Rapumerta
FI914753A0 (fi)	1991-10-09	Skydd mot inbrottstoeld foer allmaenna telefoner.
LV5577A3 (lv)	1994-05-10	Nootrops lidzeklis
KR930002100U (ko)	1993-02-25	등 때밀이대
DK200391D0 (da)	1991-12-13	Special soem
KR920015181U (ko)	1992-08-17	수력원동기
FI158U1 (fi)	1992-07-09	Skydd mot olyckor orsakade av armeringsjaern
FI394U1 (fi)	1992-11-26	Anslutning av en mellanvaegg mot undertaket
BR7101581U (pt)	1993-03-02	Calcopronto
BR7102405U (pt)	1993-04-27	Chutegol
BR9103560A (pt)	1993-03-30	Gasoteca
ATA188391A (de)	1993-05-15	Alpinski
BR7100443U (pt)	1992-11-03	Vigier
BR7100567U (pt)	1992-11-10	Auto-transponder
BR7100738U (pt)	1991-07-23	Aerofolio

Legal Events

Date	Code	Title	Description
1995-10-06	FD	Application lapsed